Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy devised by scientists at Albert Einstein College of Medicine has succeeded in making pancreatic tumors visible to the immune systems of mice and vulnerable to immune attack, reducing cancer metastases by 87%. The paper describing the findings published online today in Science Translational Medicine.
Novel therapeutic strategy shows promise against pancreatic cancer
March 24, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022